Login to Your Account



Earnings Roundup

Rebounding Amgen Trumps Q2 Estimates Despite Profit Decline

By Jennifer Boggs


Wednesday, July 30, 2008
Amgen Inc.'s second-quarter earnings outstripped Wall Street expectations and sent shares rising for the second day in a row, signaling a much-needed upturn following a year and a half of negative ESA headlines. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription